Abstract
L-Carnitine supplementation attenuates lenvatinib-induced muscle impairment without diminishing its anti-angiogenesis efficacy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1254/jpssuppl.96.0_2-b-ss02-5
Copy DOIPublication Date: Jan 1, 2022 | |
License type: open-access |
L-Carnitine supplementation attenuates lenvatinib-induced muscle impairment without diminishing its anti-angiogenesis efficacy
Join us for a 30 min session where you can share your feedback and ask us any queries you have